$4.46
0.040.9%
Last update: Nov 11, 12:16 PM
Journey Medical Corp
DERMNASDAQ
Journey Medical fell 51.2% from $9.05 to $4.42, behind the S&P 500's +9.8%. Its worst day was Mar 26 (−30.0%), and its low came Nov 5 at $4.30.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.09 missed the $-0.05 estimate on $17.6M revenue (est. $18.4M).
−15.3% · S&P 500 −1.7%
Journey Medical closed at its highest level of the year, 2.3% above where the year started.
Story events cover the past 12 months · Times ET
+4.4% · S&P 500 +0.5%
EPS of $-0.04 beat the $-0.05 estimate on $16.1M revenue (est. $18.9M).
−30.0%, the year's worst day · S&P 500 −1.8%
EPS of $-0.08 beat the $-0.08 estimate on $16.0M revenue (est. $15.4M).
+22.4%, the year's best day · S&P 500 +0.8%
EPS of $-0.01 beat the $-0.02 estimate on $17.8M revenue (est. $18.4M).
+3.4% · S&P 500 +0.7%
Journey Medical closed at its lowest level of the year, 52.5% below where the year started.
−9.1% · S&P 500 −4.4%
Where it ended: a close of $4.42 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.02, revenue est. $20.4M).
Nothing in the past 12 months.
All DERM dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DERM and SPY from Benzinga historical bars. Not investment advice.
